Drug Discovery
Ascletis Pharma Inc. Advances Oral GLP 1 And Amylin Combination For Obesity Treatment
-Fixed-dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in...
April 09, 2026 | News
Singlomics Biopharmaceuticals Doses First Patient In Phase I Trial Of DXP 106 Antibody
Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for...
April 09, 2026 | News
Toshiba Corporation Advances Quantum Inspired Computing With 100 Fold Faster Optimisation Algorithm
Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprie...
April 08, 2026 | News
Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development
Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...
April 07, 2026 | News
Alphamab Oncology Reports Phase III Success For Anbenitamab In HER2 Positive Breast Cancer
Alphamab Oncology announced that HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed wit...
April 06, 2026 | News
Regeneron And TriNetX Partner To Expand Global Genomic And EHR Linked Data Platform
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic he...
April 06, 2026 | News
NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development
NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"),...
April 02, 2026 | News
Abbisko Therapeutics Secures EMA Orphan Drug Status For Irpagratinib In Liver Cancer
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256) announced that its independently developed, highly selective, oral...
April 02, 2026 | News
Abbisko Therapeutics Secures FDA IND Clearance For ABSK061 In Achondroplasia
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced that the U.S. Food and Drug Administration has cleare...
April 01, 2026 | News
Centivax Secures 37 Million Dollars In Oversubscribed Financing To Advance Universal Influenza Vaccine
Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets,...
April 01, 2026 | News
Insilico Medicine And Eli Lilly Enter AI Led Drug Discovery Collaboration With Multibillion Dollar Potential
AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas. Insilico Medicine ("Insil...
March 31, 2026 | News
Biogen Secures Exclusive Rights To Develop Subcutaneous Biologics Using Alteogen’s ALT B4 Platform
Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 Alteogen Inc. (KOSDAQ: 196170) ann...
March 27, 2026 | News
Thermo Fisher And SHL Medical Advance Integrated Drug Device Manufacturing With Ridgefield Expansion
Collaboration and Ridgefield expansion unite fill-finish, device final assembly and packaging in a single U.S. location Thermo Fisher Scientific...
March 26, 2026 | News
Hope Medicine Initiates Phase III Trial Of HMI 115 For Endometriosis
Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III...
March 26, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
